Literature DB >> 16738331

Nucleocytoplasmic shuttling modulates activity and ubiquitination-dependent turnover of SUMO-specific protease 2.

Yoko Itahana1, Edward T H Yeh, Yanping Zhang.   

Abstract

Small ubiquitin-related modifier (SUMO) proteins are conjugated to numerous polypeptides in cells, and attachment of SUMO plays important roles in regulating the activity, stability, and subcellular localization of modified proteins. SUMO modification of proteins is a dynamic and reversible process. A family of SUMO-specific proteases catalyzes the deconjugation of SUMO-modified proteins. Members of the Sentrin (also known as SUMO)-specific protease (SENP) family have been characterized with unique subcellular localizations. However, little is known about the functional significance of or the regulatory mechanism derived from the specific localizations of the SENPs. Here we identify a bipartite nuclear localization signal (NLS) and a CRM1-dependent nuclear export signal (NES) in the SUMO protease SENP2. Both the NLS and the NES are located in the nonhomologous domains of SENP2 and are not conserved among other members of the SENP family. Using a series of SENP2 mutants and a heterokaryon assay, we demonstrate that SENP2 shuttles between the nucleus and the cytoplasm and that the shuttling is blocked by mutations in the NES or by treating cells with leptomycin B. We show that SENP2 can be polyubiquitinated in vivo and degraded through proteolysis. Restricting SENP2 in the nucleus by mutations in the NES impairs its polyubiquitination, whereas a cytoplasm-localized SENP2 made by introducing mutations in the NLS can be efficiently polyubiquitinated, suggesting that SENP2 is ubiquitinated in the cytoplasm. Finally, treating cells with MG132 leads to accumulation of polyubiquitinated SENP2, indicating that SENP2 is degraded through the 26S proteolysis pathway. Thus, the function of SENP2 is regulated by both nucleocytoplasmic shuttling and polyubiquitin-mediated degradation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16738331      PMCID: PMC1489137          DOI: 10.1128/MCB.01830-05

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  25 in total

1.  Herpes simplex virus 1 ICP0 co-localizes with a SUMO-specific protease.

Authors:  Daniel Bailey; Peter O'Hare
Journal:  J Gen Virol       Date:  2002-12       Impact factor: 3.891

2.  Characterization of the localization and proteolytic activity of the SUMO-specific protease, SENP1.

Authors:  Daniel Bailey; Peter O'Hare
Journal:  J Biol Chem       Date:  2003-10-16       Impact factor: 5.157

Review 3.  SUMO: ligases, isopeptidases and nuclear pores.

Authors:  Frauke Melchior; Marion Schergaut; Andrea Pichler
Journal:  Trends Biochem Sci       Date:  2003-11       Impact factor: 13.807

Review 4.  Protein modification by SUMO.

Authors:  Erica S Johnson
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

Review 5.  SUMO and ubiquitin in the nucleus: different functions, similar mechanisms?

Authors:  Grace Gill
Journal:  Genes Dev       Date:  2004-09-01       Impact factor: 11.361

6.  Nucleocytoplasmic shuttling of p53 is essential for MDM2-mediated cytoplasmic degradation but not ubiquitination.

Authors:  Kevin O'Keefe; Huiping Li; Yanping Zhang
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

Review 7.  Nuclear localization signals (NLS).

Authors:  T Boulikas
Journal:  Crit Rev Eukaryot Gene Expr       Date:  1993       Impact factor: 1.807

8.  A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes.

Authors:  Dehuang Guo; Manyu Li; Yan Zhang; Ping Yang; Sarah Eckenrode; Diane Hopkins; Weipeng Zheng; Sharad Purohit; Robert H Podolsky; Andrew Muir; Jinzhao Wang; Zheng Dong; Todd Brusko; Mark Atkinson; Paolo Pozzilli; Adina Zeidler; Leslie J Raffel; Chaim O Jacob; Yongsoo Park; Manuel Serrano-Rios; Maria T Martinez Larrad; Zixin Zhang; Henri-Jean Garchon; Jean-Francois Bach; Jerome I Rotter; Jin-Xiong She; Cong-Yi Wang
Journal:  Nat Genet       Date:  2004-07-11       Impact factor: 38.330

9.  SENP1 enhances androgen receptor-dependent transcription through desumoylation of histone deacetylase 1.

Authors:  Jinke Cheng; Dachun Wang; Zhengxin Wang; Edward T H Yeh
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

10.  A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus.

Authors:  Kurt M Bohren; Varsha Nadkarni; Jian H Song; Kenneth H Gabbay; David Owerbach
Journal:  J Biol Chem       Date:  2004-04-29       Impact factor: 5.157

View more
  47 in total

1.  A novel mechanism for SUMO system control: regulated Ulp1 nucleolar sequestration.

Authors:  Yaroslav Sydorskyy; Tharan Srikumar; Stanley M Jeram; Sarah Wheaton; Franco J Vizeacoumar; Taras Makhnevych; Yolanda T Chong; Anne-Claude Gingras; Brian Raught
Journal:  Mol Cell Biol       Date:  2010-07-20       Impact factor: 4.272

2.  Overexpression of SUMO-1 in hepatocellular carcinoma: a latent target for diagnosis and therapy of hepatoma.

Authors:  Wu-Hua Guo; Li-Hua Yuan; Zhi-Hua Xiao; Dan Liu; Ji-Xiang Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2010-05-26       Impact factor: 4.553

3.  Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation.

Authors:  Mikael S Lindström; Aiwen Jin; Chad Deisenroth; Gabrielle White Wolf; Yanping Zhang
Journal:  Mol Cell Biol       Date:  2006-11-20       Impact factor: 4.272

Review 4.  Role of desumoylation in the development of prostate cancer.

Authors:  Jinke Cheng; Tasneem Bawa; Peng Lee; Limin Gong; Edward T H Yeh
Journal:  Neoplasia       Date:  2006-08       Impact factor: 5.715

Review 5.  SUMOylation and De-SUMOylation: wrestling with life's processes.

Authors:  Edward T H Yeh
Journal:  J Biol Chem       Date:  2008-11-13       Impact factor: 5.157

Review 6.  SUMO rules: regulatory concepts and their implication in neurologic functions.

Authors:  Mathias Droescher; Viduth K Chaugule; Andrea Pichler
Journal:  Neuromolecular Med       Date:  2013-08-30       Impact factor: 3.843

7.  De-SUMOylation enzyme of sentrin/SUMO-specific protease 2 regulates disturbed flow-induced SUMOylation of ERK5 and p53 that leads to endothelial dysfunction and atherosclerosis.

Authors:  Kyung-Sun Heo; Eugene Chang; Nhat-Tu Le; Hannah Cushman; Edward T H Yeh; Keigi Fujiwara; Jun-ichi Abe
Journal:  Circ Res       Date:  2013-02-04       Impact factor: 17.367

8.  The SUMO-Specific Protease Senp2 Regulates SUMOylation, Expression and Function of Human Organic Anion Transporter 3.

Authors:  Haoxun Wang; Guofeng You
Journal:  Biochim Biophys Acta Biomembr       Date:  2019-05-01       Impact factor: 3.747

9.  The E3 ligase APC/C-Cdh1 regulates MEF2A-dependent transcription by targeting SUMO-specific protease 2 for ubiquitination and degradation.

Authors:  Han Lu; Bin Liu; Fu-Jun Zhang; Jin Zhang; Rong Dong; Lei Chen; Dong-Mei Qu; Yan Lu; Bu-Wei Yu
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

10.  SENP2 regulates MEF2A de-SUMOylation in an activity dependent manner.

Authors:  Han Lu; Bin Liu; Shengwu You; Lei Chen; Qu Dongmei; Minjie Gu; Yan Lu; Yingyi Chen; Fujun Zhang; Buwei Yu
Journal:  Mol Biol Rep       Date:  2012-12-08       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.